糖尿病孕妇的特异性出生缺陷:国家出生缺陷预防研究,1997-2011年
基于美国国家出生缺陷预防研究1997年10月至2011年12月的病例对照数据,分析孕前糖尿病与妊娠期糖尿病和特异性结构出生缺陷的关联。孕前糖尿病与50种出生缺陷中的46种呈显著关联(比值比范围2.5-80.2),妊娠期糖尿病关联较少且较弱(56种中12种显著,比值比范围1.3-2.1)。
要点
- 孕前糖尿病与46/50种出生缺陷显著相关,比值比最高达80.2(骶骨发育不全)。
- 妊娠期糖尿病仅与12/56种出生缺陷显著相关,比值比较小(1.3-2.1)。
- 孕前血糖控制与出生缺陷风险降低相关,持续优质照护是预防机会。
核心结论
- 孕前糖尿病与多种特异性出生缺陷风险显著增加相关。
- 孕前血糖控制与出生缺陷风险降低相关,持续优质照护是重要预防机会。
研究设计与样本
- 国家出生缺陷预防研究(美国最大基于人群的出生缺陷病例对照研究),分析1997年10月至2011年12月的分娩数据。
- 病例婴儿母亲31007例,对照婴儿母亲11447例,通过访谈收集孕期糖尿病诊断等信息。
- 采用逻辑回归分别评估孕前糖尿病和妊娠期糖尿病与特定结构出生缺陷类别的关联;暴露病例≥5例的缺陷类别计算调整比值比(调整母亲体重指数、年龄、教育、种族/民族和研究 site),暴露病例3-4例的计算粗比值比。
主要发现
- 对照婴儿母亲中孕前糖尿病报告率为0.6%(71/11447),病例婴儿母亲中为2.5%(775/31007)。
- 对照婴儿母亲中妊娠期糖尿病报告率为4.7%(536/11447),病例婴儿母亲中为5.3%(1653/31007)。
- 孕前糖尿病与50种出生缺陷中的46种呈强且统计学显著的比值比(范围2.5-80.2)。
- 骶骨发育不全的调整比值比最大(调整比值比80.2,95%置信区间46.1-139.3);前脑无裂畸形(调整比值比13.1,95%置信区间7.0-24.5)、纵向肢体缺陷(调整比值比10.1,95%置信区间6.2-16.5)、异位综合征(调整比值比12.3,95%置信区间7.3-20.5)、共同动脉干(调整比值比14.9,95%置信区间7.6-29.3)、房室间隔缺损(调整比值比10.5,95%置信区间6.2-17.9)和单心室复合畸形(调整比值比14.7,95%置信区间8.9-24.3)的风险增加超过10倍。
- 妊娠期糖尿病统计学显著的比值比较少(56种中12种)且幅度较小(范围1.3-2.1;腹裂为0.5)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes is associated with an increased risk for many birth defects and is likely to have an increasing impact on birth defect prevalence because of the rise in diabetes in the United States in recent decades. One of the first analyses in which specific birth defects were assessed for their relationship with both pregestational and gestational diabetes used data from the initial 6 years of the National Birth Defects Prevention Study. That analysis reported strong associations for pregestational diabetes with several birth defects, but few exposures among some of the less common birth defects led to unstable estimates with wide confidence intervals. Since that analysis, the study continued to collect data for another 8 years, including information on approximately 19,000 additional cases and 6900 additional controls. OBJECTIVE: Our objective was to use data from the National Birth Defects Prevention Study, the largest population-based birth defects case-control study in the United States, to provide updated and more precise estimates of the association between diabetes and birth defects, including some defects not previously assessed. STUDY DESIGN: We analyzed data on deliveries from October 1997 through December 2011. Mothers of case and control infants were interviewed about their health conditions and exposures during pregnancy, including diagnosis of pregestational (type 1 or type 2) diabetes before the index pregnancy or gestational diabetes during the index pregnancy. Using logistic regression, we separately assessed the association between pregestational and gestational diabetes with specific categories of structural birth defects for which there were at least 3 exposed case infants. For birth defect categories for which there were at least 5 exposed case infants, we calculated odds ratios adjusted for maternal body mass index, age, education, race/ethnicity, and study site; for defect categories with 3 or 4 exposed cases, we calculated crude odds ratios. RESULTS: Pregestational diabetes was reported by 0.6% of mothers of control infants (71 of 11,447) and 2.5% of mothers of case infants (775 of 31,007). Gestational diabetes during the index pregnancy was reported by 4.7% of mothers of control infants (536 of 11,447) and 5.3% of mothers of case infants (1,653 of 31,007). Pregestational diabetes was associated with strong, statistically significant odds ratios (range, 2.5-80.2) for 46 of 50 birth defects considered. The largest odds ratio was observed for sacral agenesis (adjusted odds ratio, 80.2; 95% confidence interval, 46.1-139.3). A greater than 10-fold increased risk was also observed for holoprosencephaly (adjusted odds ratio, 13.1; 95% confidence interval, 7.0-24.5), longitudinal limb deficiency (adjusted odds ratio, 10.1; 95% confidence interval, 6.2-16.5), heterotaxy (adjusted odds ratio, 12.3; 95% confidence interval, 7.3-20.5), truncus arteriosus (adjusted odds ratio, 14.9; 95% confidence interval, 7.6-29.3), atrioventricular septal defect (adjusted odds ratio, 10.5; 95% confidence interval, 6.2-17.9), and single ventricle complex (adjusted odds ratio, 14.7; 95% confidence interval, 8.9-24.3). For gestational diabetes, statistically significant odds ratios were fewer (12 of 56) and of smaller magnitude (range, 1.3- 2.1; 0.5 for gastroschisis). CONCLUSION: Pregestational diabetes is associated with a markedly increased risk for many specific births defects. Because glycemic control before pregnancy is associated with a reduced risk for birth defects, ongoing quality care for persons with diabetes is an important opportunity for prevention.
引用
- Tinker SC, Gilboa SM, Moore CA, et al. Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011. Am J Obstet Gynecol. 2019. PMID: 31454511. doi:10.1016/j.ajog.2019.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。